184 related articles for article (PubMed ID: 14575568)
1. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
5. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
Thompson PA; Shields PG; Freudenheim JL; Stone A; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Kadlubar FF; Ambrosone CB
Cancer Res; 1998 May; 58(10):2107-10. PubMed ID: 9605753
[TBL] [Abstract][Full Text] [Related]
9. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
[TBL] [Abstract][Full Text] [Related]
11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.
Bergman-Jungeström M; Wingren S
Br J Cancer; 2001 Sep; 85(6):859-62. PubMed ID: 11556837
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Goodman JE; Lavigne JA; Hengstler JG; Tanner B; Helzlsouer KJ; Yager JD
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1373-6. PubMed ID: 11142424
[TBL] [Abstract][Full Text] [Related]
15. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
Al-Hendy A; Salama SA
J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
[TBL] [Abstract][Full Text] [Related]
17. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
18. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
19. COMT gene Val158Met polymorphism influences the severity of intestinal metaplasia in H. pylori infected older subjects.
Tahara T; Shibata T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Yamashita H; Nakano H; Hirata I; Arisawa T
Hepatogastroenterology; 2009; 56(90):411-5. PubMed ID: 19579610
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
